55174-61-3

Basic information

• Product Name: 3,4-dimethoxy-beta-methylphenethylamine
• Synonyms: 3,4-dimethoxy-beta-methylphenethylamine;2-(3,4-DiMethoxyphenyl)propan-1-aMine
• CAS NO: 55174-61-3
• Molecular Formula: C₁₁H₁₇NO₂
• Molecular Weight: 195.25818
• EINECS: 259-510-9
• Mol File: 55174-61-3.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 3,4-dimethoxy-beta-methylphenethylamine(CAS DataBase Reference)
• NIST Chemistry Reference: 3,4-dimethoxy-beta-methylphenethylamine(55174-61-3)
• EPA Substance Registry System: 3,4-dimethoxy-beta-methylphenethylamine(55174-61-3)

Safety Data

• Hazardous Substances Data: 55174-61-3(Hazardous Substances Data)

Usage

General Description

3,4-dimethoxy-beta-methylphenethylamine, also known as 3C-E, is a psychedelic phenethylamine with a chemical structure similar to mescaline and other designer drugs. It is derived from the beta-methylphenethylamine class of compounds and is known for its hallucinogenic and stimulating effects. 3C-E is a potent serotonin receptor agonist, meaning it interacts with serotonin receptors in the brain to produce its psychoactive effects. It is often used recreationally for its euphoric and hallucinogenic properties, and has been implicated in a number of drug-related deaths and hospitalizations due to its potent effects on the central nervous system. The use of 3C-E is not regulated in many countries, making it easily accessible through online vendors and underground markets, but its risks and potential for addiction and overdose make it a dangerous substance to use.

Upstream product

• 74156-75-5 2-(3,4-dimethoxyphenyl)propanoic acid chloride 
• 51698-53-4 2‐(3,4‐dimethoxyphenyl)propionitrile 
• 93-17-4 3,4-dimethoxyphenylacetonitrile 
• 138505-14-3 2-(3,4-dimethoxyphenyl)propanoic acid 
• 18066-68-7 ethyl 3,4-dimethoxyphenylacetate 
• 73941-24-9 3-(3,4-dimethoxy-phenyl)-butyric acid amide 

Downstream Products

• 717854-32-5 N-[2-(3,4-dimethoxy-phenyl)-propyl]-veratramide 
• 2494-12-4 N-acetyldopamine 
• 76210-68-9 1-[2-(3,4-Dimethoxy-phenyl)-1-methyl-ethylamino]-3-phenoxy-propan-2-ol; hydrochloride 
• 18029-55-5 4-Methyl-6,7-dimethoxy-isochinolin 
• 1239326-04-5 1,2,3,4-tetrahydro-6,7-dimethoxy-4-methyl-1-phenylisoquinoline 
• 859962-91-7 1-(3,4-dimethoxy-phenyl)-6,7-dimethoxy-4-methyl-3,4-dihydro-isoquinoline 
• 20225-95-0 1-(3,4-dimethoxy-phenyl)-6,7-dimethoxy-4-methyl-isoquinoline 
• 66432-25-5 (+/-)-beta-methyldopamine 
• 122212-64-0 N-<2-(3,4-Dimethoxyphenyl)propyl>trifluoracetamid 

Relevant articles and documents

Structure and Biocatalytic Scope of Coclaurine N-Methyltransferase

Benzylisoquinoline alkaloids (BIAs) are a structurally diverse family of plant secondary metabolites, which have been exploited to develop analgesics, antibiotics, antitumor agents, and other therapeutic agents. Biosynthesis of BIAs proceeds via a common pathway from tyrosine to (S)-reticulene at which point the pathway diverges. Coclaurine N-methyltransferase (CNMT) is a key enzyme in the pathway to (S)-reticulene, installing the N-methyl substituent that is essential for the bioactivity of many BIAs. In this paper, we describe the first crystal structure of CNMT which, along with mutagenesis studies, defines the enzymes active site architecture. The specificity of CNMT was also explored with a range of natural and synthetic substrates as well as co-factor analogues. Knowledge from this study could be used to generate improved CNMT variants required to produce BIAs or synthetic derivatives.

NOVEL DIHYDROQUINOLIZINONES FOR THE TREATMENT AND PROPHYLAXIS OF HEPATITIS B VIRUS INFECTION

The invention provides novel compounds having the general formula (I) wherein R1, R2 R3, R4, R5 and R6 are as described herein, compositions including the compounds and methods of using the compounds in the treatment of the hepatitis B virus.